1. A Bayesian design for phase II clinical trials with delayed responses based on multiple imputation. (12th May 2014) Authors: Cai, Chunyan; Liu, Suyu; Yuan, Ying Journal: Statistics in medicine Issue: Volume 33:Number 23(2014) Page Start: 4017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent. Issue 5 (14th June 2021) Authors: Guo, Beibei; Garrett‐Mayer, Elizabeth; Liu, Suyu Journal: Journal of the Royal Statistical Society Issue: Volume 70:Issue 5(2021) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Bayesian Phase I/II Design for Cancer Clinical Trials Combining an Immunotherapeutic Agent with a Chemotherapeutic Agent. Issue 5 (17th November 2021) Authors: Guo, Beibei; Garrett-Mayer, Elizabeth; Liu, Suyu Journal: Journal of the Royal Statistical Society Issue: Volume 70:Issue 5(2021) Page Start: 1210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Bayesian Phase I/II Trial Design for Immunotherapy. Issue 523 (3rd July 2018) Authors: Liu, Suyu; Guo, Beibei; Yuan, Ying Journal: Journal of the American Statistical Association Issue: Volume 113:Issue 523(2018) Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. (27th February 2017) Authors: Balasenthil, Seetharaman; Huang, Ying; Liu, Suyu; Marsh, Tracey; Chen, Jinyun; Stass, Sanford A.; KuKuruga, Debra; Brand, Randall; Chen, Nanyue; Frazier, Marsha L.; Jack Lee, J.; Srivastava, Sudhir; Sen, Subrata; McNeill Killary, Ann Journal: Journal of the National Cancer Institute Issue: Volume 109:Number 8(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Utility-Based Bayesian Phase I–II Design for Immunotherapy Trials with Progression-Free Survival End Point. Issue 2 (18th May 2018) Authors: Guo, Beibei; Park, Yeonhee; Liu, Suyu Journal: Journal of the Royal Statistical Society Issue: Volume 68:Issue 2(2019) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A utility‐based Bayesian phase I–II design for immunotherapy trials with progression‐free survival end point. Issue 2 (18th May 2018) Authors: Guo, Beibei; Park, Yeonhee; Liu, Suyu Journal: Journal of the Royal Statistical Society Issue: Volume 68:Issue 2(2019) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints. Issue 2 (12th August 2019) Authors: Guo, Beibei; Liu, Suyu Journal: Biometrical journal Issue: Volume 62:Issue 2(2020:Mar.) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Antifungal activity of designed α-helical antimicrobial peptides. (1st March 2023) Authors: Xu, Ruicheng; Tang, Jing; Hadianamrei, Roja; Liu, Suyu; Lv, Songwei; You, Rongrong; Pan, Fang; Zhang, Peng; Wang, Nan; Cai, Zhiqiang; Zhao, Xiubo Journal: Biomaterials science Issue: Volume 11:Number 8(2023) Page Start: 2845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers. Issue 1 (27th January 2021) Authors: Park, Yeonhee; Liu, Suyu; Thall, Peter F.; Yuan, Ying Journal: Biometrics Issue: Volume 78:Issue 1(2022) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗